Effects of dienogest (a synthetic steroid) on coagulation, fibrinolysis, and platelet aggregation in female monkeys

Toxicology Letters

Volumn 98, Issue 1-2, 1998, Pages 105-113

  Katsuki, Yukio ^a   Nobukata, Hidefumi ^a   Ishikawa, Tsutomu ^a   Hamada, Yoshimasa ^a   Sato, Masami ^a   Shibutani, Yasunori ^a  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

Coagulation; Danazol; Dienogest; Medroxyprogesterone acetate; Monkeys; Platelet aggregation

Indexed keywords

BLOOD CLOTTING FACTOR; DANAZOL; DIENOGEST; MEDROXYPROGESTERONE ACETATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FIBRINOLYSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHESUS MONKEY; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; CHOLESTEROL; DANAZOL; FEMALE; FIBRINOLYSIS; HORMONE ANTAGONISTS; MACACA FASCICULARIS; MACACA MULATTA; MEDROXYPROGESTERONE 17-ACETATE; NANDROLONE; PHOSPHOLIPIDS; PLATELET AGGREGATION;

MACACA FASCICULARIS; MACACA MULATTA;

EID: 0032169126     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00109-X     Document Type: Article

References (27)

1. Abbate R., Pinto S., Rostagno C., Bruni V., Rosati D., Mariani G. Effects of long-term gestoden-containing oral contraceptive administration on hemostasis. Am. J. Obstet. Gynecol. 163:1990;424-430.
2. Arai M., Matsuura T., Yamada T., Kim Y., Kiriishi R., Hara Y., Hara T., Hara Y., Saishin M. Papilledema and cerebral venous sinus thrombosis developed in a case during systemic treatment for endometriosis. Jpn. J. Clin. Ophthalmol. 47:1993;754-755.
3. Balleisen L., Bailey J., Epping P.H., Schulte H., Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: 1. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb. Haemost. 54:1985;475-479.
4. Barbieri R.L., Ryan K.J. Danazol: endocrine pharmacology and therapeutic applications. Am. J. Obstet. Gynecol. 141:1981;453-463.
5. Beller F.K., Ebert C. Effects of oral contraceptives on blood coagulation. A review. Obstet. Gynecol. Surv. 40:1985;425-436.
6. Bonnar J., Daly L., Carroll E. Blood coagulation with a combination pill containing gestoden and ethinyl estradiol. Int. J. Fertil. 32:1987;21-28.
7. Corno M., Vallar G., Scarlato G., Meola G. Danazol and internal carotid artery thrombosis. Eur. Neurol. 29:1989;235-237.
8. 3H) estra-4, 9-dien-3-one. J. Label. Compd. Radiopham. 36:1995;111-119.
9. Fukuda Y., Nagai K., Kanamoto O.Y., Asai S. Two cases of cerebral infarction following administration of high dose medroxyprogesterone (MPA). Neurol. Med. 29:1988;447-448.
10. Hamed L.M., Glaser J.S., Schatz N.J., Perez T.H. Pseudotumor cerebri induced by danazol. Am. J. Ophthalmol. 107:1989;105-110.
11. Hibino H., Matsubara M., Kabasawa H., Kamimoto K. Cerebral infarction by danazol. A case report. Neurol. Med. 38:1993;179-182.
12. Hochberg Y., Tamhane A.C. Multiple Comparison Procedures. 1987;134-160 Wiley, New York.
13. Jin O.C., Sun L.Y. Medullary infarction - was it depo-provera? Singapore Med. J. 21:1980;717-719.
14. Katsuki Y., Sasagawa S., Takano Y., Shibutani Y., Aoki D., Udagawa Y., Nozawa S. Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid. Drugs Exp. Clin. Res. 23:1997;45-62.
15. Katsuki Y., Shibutani Y., Aoki D., Nozawa S. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins. Cancer. 9:1997;169-176.
16. Köhler G., Göretzlehner G., Rüdolf K., Ruting M., Meissner J., Kunkel S., Chollberg K. The effect of a single midcycle administration of 0.5 or 2.0 mg dienogest (17α-cyanomethyl-17β-hydroxy-estra-4, 9-dien-3-one) on pituitary and ovarian function-Investigation for the use as a postcoital contraceptive. Exp. Clin. Endocrinol. 84:1984;299-304.
17. Lauersen N.H., Wilson K.H., Birnbaum S. Danazol: an antigonadotropic agent in the treatment of pelvic endometriosis. Am. J. Obstet. Gynecol. 123:1975;742-747.
18. Moghissi K.S., Boyce C.R. Management of endometriosis with oral medroxyprogesterone acetate. Obstet. Gynecol. 47:1976;265-267.
19. Nakagawa T., Yasuno M., Tanahashi H., Ohnishi S., Nishino M., Yamada Y., Abe H. A case of acute myocardial infarction. Intracoronary thrombosis in two major coronary arteries due to hormone therapy. Angiology. 45:1994;333-338.
20. Notelovitz M., Kitchens C.S., Khan F.Y. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. Am. J. Obstet. Gynecol. 167:1992;1255-1261.
21. Oettel M., Kurichko A. STS 557, a new orally active progestin with antiprogestational and contragestational properties in rabbits. Contraception. 21:1980;61-75.
22. Rannevilk G. Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis. Postgrad. Med. J. (Suppl.). 55:1979;14-20.
23. Roland M., Leisten D., Kane R. Endometriosis therapy with medroxyprogesterone acetate. J. Reprod. Med. 17:1976;249-252.
24. Sato T., Maegawa H., Kometani M., Fujii T. Collagen-induced calcium influx is enhanced in platelets from hypercholesterolemic rabbits. Thromb. Res. 40:1985;59-68.
25. Schubert K., Hobe G., Kaufmann G., Koch M., Hübner M., Strecke J. Synthesis, effects, and metabolism of the progestogen and potential interceptive dienogest. Zalewski R.R., Stolik J.J. Natural Products Chemistry 1984. 1985;143-158 Elsevier, Amsterdam.
26. Veelen H., Willemse P.H.B., Tjabbes T., Schweitzer M.J.H., Sleijfer D.T. Oral high-dose medroxyprogesterone acetate versus tamoxifen - a randomized crossover trial in postmenopausal patients with advanced breast cancer. Cancer. 58:1986;7-13.
27. Weinges K.F., Wenzel E., Hellstern P., Geurts T.B.P., Dieben T.O.M. The effects of two phasic oral contraceptives on hemostasis and platelet function. Adv. Contracept. 11:1995;227-237.